nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—MET—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0243	0.0567	CbGpPWpGaD
Crizotinib—PRKD3—pancreas—sclerosing cholangitis	0.0172	0.0301	CbGeAlD
Crizotinib—PRKD1—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.016	0.0372	CbGpPWpGaD
Crizotinib—MAPK7—pancreas—sclerosing cholangitis	0.0159	0.0278	CbGeAlD
Crizotinib—MET—pancreas—sclerosing cholangitis	0.0149	0.026	CbGeAlD
Crizotinib—ACVR1B—pancreas—sclerosing cholangitis	0.0137	0.0241	CbGeAlD
Crizotinib—NEK9—liver—sclerosing cholangitis	0.0125	0.0219	CbGeAlD
Crizotinib—IGF1R—pancreas—sclerosing cholangitis	0.0117	0.0205	CbGeAlD
Crizotinib—IGF1R—Apoptosis—TNFRSF25—sclerosing cholangitis	0.0117	0.0272	CbGpPWpGaD
Crizotinib—RPS6KB1—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0113	0.0264	CbGpPWpGaD
Crizotinib—SIK2—liver—sclerosing cholangitis	0.0112	0.0197	CbGeAlD
Crizotinib—PRKD3—liver—sclerosing cholangitis	0.0109	0.0192	CbGeAlD
Crizotinib—CASK—liver—sclerosing cholangitis	0.0104	0.0183	CbGeAlD
Crizotinib—NUAK2—pancreas—sclerosing cholangitis	0.0104	0.0182	CbGeAlD
Crizotinib—ACVR1—pancreas—sclerosing cholangitis	0.0103	0.0181	CbGeAlD
Crizotinib—STK35—pancreas—sclerosing cholangitis	0.0101	0.0177	CbGeAlD
Crizotinib—PRKD1—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.0101	0.0235	CbGpPWpGaD
Crizotinib—FES—liver—sclerosing cholangitis	0.01	0.0175	CbGeAlD
Crizotinib—TEK—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.00995	0.0232	CbGpPWpGaD
Crizotinib—MET—liver—sclerosing cholangitis	0.00946	0.0166	CbGeAlD
Crizotinib—TIE1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00922	0.0215	CbGpPWpGaD
Crizotinib—CDK7—liver—sclerosing cholangitis	0.00915	0.016	CbGeAlD
Crizotinib—ROS1—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.0091	0.0212	CbGpPWpGaD
Crizotinib—TAOK2—liver—sclerosing cholangitis	0.00908	0.0159	CbGeAlD
Crizotinib—ACVR1B—liver—sclerosing cholangitis	0.00874	0.0153	CbGeAlD
Crizotinib—PTK2—pancreas—sclerosing cholangitis	0.00867	0.0152	CbGeAlD
Crizotinib—TBK1—pancreas—sclerosing cholangitis	0.00867	0.0152	CbGeAlD
Crizotinib—TYK2—pancreas—sclerosing cholangitis	0.00861	0.0151	CbGeAlD
Crizotinib—IRAK1—pancreas—sclerosing cholangitis	0.0085	0.0149	CbGeAlD
Crizotinib—RPS6KB1—pancreas—sclerosing cholangitis	0.00834	0.0146	CbGeAlD
Crizotinib—STK4—liver—sclerosing cholangitis	0.00819	0.0143	CbGeAlD
Crizotinib—TEK—Angiogenesis—HIF1A—sclerosing cholangitis	0.00818	0.0191	CbGpPWpGaD
Crizotinib—IGF1R—Endochondral Ossification—ALPL—sclerosing cholangitis	0.00807	0.0188	CbGpPWpGaD
Crizotinib—SLK—pancreas—sclerosing cholangitis	0.00795	0.0139	CbGeAlD
Crizotinib—EPHB4—pancreas—sclerosing cholangitis	0.00789	0.0138	CbGeAlD
Crizotinib—EPHA2—pancreas—sclerosing cholangitis	0.00774	0.0136	CbGeAlD
Crizotinib—FER—liver—sclerosing cholangitis	0.00774	0.0136	CbGeAlD
Crizotinib—LYN—liver—sclerosing cholangitis	0.0077	0.0135	CbGeAlD
Crizotinib—TNK1—liver—sclerosing cholangitis	0.00766	0.0134	CbGeAlD
Crizotinib—TEK—pancreas—sclerosing cholangitis	0.00755	0.0132	CbGeAlD
Crizotinib—MAP4K5—pancreas—sclerosing cholangitis	0.00755	0.0132	CbGeAlD
Crizotinib—TNK2—liver—sclerosing cholangitis	0.00743	0.013	CbGeAlD
Crizotinib—IGF1R—liver—sclerosing cholangitis	0.00743	0.013	CbGeAlD
Crizotinib—IGF1R—Apoptosis—BCL2L11—sclerosing cholangitis	0.00736	0.0172	CbGpPWpGaD
Crizotinib—MAP4K2—liver—sclerosing cholangitis	0.00733	0.0128	CbGeAlD
Crizotinib—TIE1—liver—sclerosing cholangitis	0.00723	0.0127	CbGeAlD
Crizotinib—STK3—liver—sclerosing cholangitis	0.00723	0.0127	CbGeAlD
Crizotinib—AURKA—liver—sclerosing cholangitis	0.00705	0.0123	CbGeAlD
Crizotinib—TESK1—liver—sclerosing cholangitis	0.00699	0.0122	CbGeAlD
Crizotinib—YES1—pancreas—sclerosing cholangitis	0.00698	0.0122	CbGeAlD
Crizotinib—TAOK3—pancreas—sclerosing cholangitis	0.00689	0.0121	CbGeAlD
Crizotinib—MERTK—liver—sclerosing cholangitis	0.0068	0.0119	CbGeAlD
Crizotinib—BLK—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00679	0.0158	CbGpPWpGaD
Crizotinib—SRC—pancreas—sclerosing cholangitis	0.00671	0.0118	CbGeAlD
Crizotinib—LIMK2—liver—sclerosing cholangitis	0.00665	0.0116	CbGeAlD
Crizotinib—NUAK2—liver—sclerosing cholangitis	0.00663	0.0116	CbGeAlD
Crizotinib—MAP3K12—liver—sclerosing cholangitis	0.00658	0.0115	CbGeAlD
Crizotinib—FLT3—liver—sclerosing cholangitis	0.00658	0.0115	CbGeAlD
Crizotinib—ACVR1—liver—sclerosing cholangitis	0.00658	0.0115	CbGeAlD
Crizotinib—STK35—liver—sclerosing cholangitis	0.00645	0.0113	CbGeAlD
Crizotinib—ABL2—liver—sclerosing cholangitis	0.00628	0.011	CbGeAlD
Crizotinib—BMP2K—liver—sclerosing cholangitis	0.0062	0.0109	CbGeAlD
Crizotinib—RPS6KB1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00618	0.0144	CbGpPWpGaD
Crizotinib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.00613	0.0143	CbGpPWpGaD
Crizotinib—PTK2B—liver—sclerosing cholangitis	0.00599	0.0105	CbGeAlD
Crizotinib—RIPK2—liver—sclerosing cholangitis	0.00594	0.0104	CbGeAlD
Crizotinib—MAPK7—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00592	0.0138	CbGpPWpGaD
Crizotinib—PTK2B—Coregulation of Androgen receptor activity—TCF4—sclerosing cholangitis	0.0058	0.0135	CbGpPWpGaD
Crizotinib—MAP3K2—liver—sclerosing cholangitis	0.00563	0.00987	CbGeAlD
Crizotinib—RIPK2—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00555	0.0129	CbGpPWpGaD
Crizotinib—PTK2—liver—sclerosing cholangitis	0.00552	0.00966	CbGeAlD
Crizotinib—TBK1—liver—sclerosing cholangitis	0.00552	0.00966	CbGeAlD
Crizotinib—TYK2—liver—sclerosing cholangitis	0.00548	0.0096	CbGeAlD
Crizotinib—IRAK1—liver—sclerosing cholangitis	0.00541	0.00947	CbGeAlD
Crizotinib—RPS6KB1—liver—sclerosing cholangitis	0.00531	0.0093	CbGeAlD
Crizotinib—PTK2—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.0053	0.0124	CbGpPWpGaD
Crizotinib—FGR—liver—sclerosing cholangitis	0.00528	0.00924	CbGeAlD
Crizotinib—LCK—liver—sclerosing cholangitis	0.00528	0.00924	CbGeAlD
Crizotinib—AXL—liver—sclerosing cholangitis	0.00525	0.0092	CbGeAlD
Crizotinib—NTRK1—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00524	0.0122	CbGpPWpGaD
Crizotinib—IRAK1—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00518	0.0121	CbGpPWpGaD
Crizotinib—SLK—liver—sclerosing cholangitis	0.00506	0.00886	CbGeAlD
Crizotinib—EPHB4—liver—sclerosing cholangitis	0.00502	0.00879	CbGeAlD
Crizotinib—JAK2—liver—sclerosing cholangitis	0.00499	0.00873	CbGeAlD
Crizotinib—EPHA2—liver—sclerosing cholangitis	0.00493	0.00863	CbGeAlD
Crizotinib—RIPK2—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00483	0.0113	CbGpPWpGaD
Crizotinib—MAP4K5—liver—sclerosing cholangitis	0.00481	0.00842	CbGeAlD
Crizotinib—MAP3K3—liver—sclerosing cholangitis	0.00481	0.00842	CbGeAlD
Crizotinib—TEK—liver—sclerosing cholangitis	0.00481	0.00842	CbGeAlD
Crizotinib—ABL1—pancreas—sclerosing cholangitis	0.00476	0.00834	CbGeAlD
Crizotinib—NTRK1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.0047	0.011	CbGpPWpGaD
Crizotinib—MAPK7—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00468	0.0109	CbGpPWpGaD
Crizotinib—YES1—liver—sclerosing cholangitis	0.00444	0.00777	CbGeAlD
Crizotinib—STK10—liver—sclerosing cholangitis	0.0044	0.0077	CbGeAlD
Crizotinib—TAOK3—liver—sclerosing cholangitis	0.00438	0.00767	CbGeAlD
Crizotinib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00432	0.0101	CbGpPWpGaD
Crizotinib—PTK2—Angiogenesis—HIF1A—sclerosing cholangitis	0.00431	0.0101	CbGpPWpGaD
Crizotinib—BLK—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00428	0.00997	CbGpPWpGaD
Crizotinib—SRC—liver—sclerosing cholangitis	0.00427	0.00748	CbGeAlD
Crizotinib—MAP3K2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00426	0.00993	CbGpPWpGaD
Crizotinib—MAPK7—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00413	0.00962	CbGpPWpGaD
Crizotinib—IRAK1—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00407	0.0095	CbGpPWpGaD
Crizotinib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00388	0.00904	CbGpPWpGaD
Crizotinib—CSF1R—liver—sclerosing cholangitis	0.00383	0.00671	CbGeAlD
Crizotinib—MAP3K2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00376	0.00876	CbGpPWpGaD
Crizotinib—NTRK1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00368	0.00857	CbGpPWpGaD
Crizotinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00361	0.00842	CbGpPWpGaD
Crizotinib—IRAK1—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00355	0.00827	CbGpPWpGaD
Crizotinib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00354	0.00826	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00347	0.00808	CbGpPWpGaD
Crizotinib—PTK2—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00332	0.00775	CbGpPWpGaD
Crizotinib—EPHA7—Developmental Biology—TCF4—sclerosing cholangitis	0.0033	0.00769	CbGpPWpGaD
Crizotinib—TEK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00327	0.00763	CbGpPWpGaD
Crizotinib—IRAK1—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00326	0.00761	CbGpPWpGaD
Crizotinib—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00313	0.00729	CbGpPWpGaD
Crizotinib—PTK2B—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00304	0.00708	CbGpPWpGaD
Crizotinib—EPHA3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00303	0.00706	CbGpPWpGaD
Crizotinib—ABL1—liver—sclerosing cholangitis	0.00303	0.00531	CbGeAlD
Crizotinib—NTRK1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00291	0.00677	CbGpPWpGaD
Crizotinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00286	0.00667	CbGpPWpGaD
Crizotinib—SRC—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00283	0.00659	CbGpPWpGaD
Crizotinib—RPS6KB1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00282	0.00657	CbGpPWpGaD
Crizotinib—CYP3A5—pancreas—sclerosing cholangitis	0.00279	0.00488	CbGeAlD
Crizotinib—JAK3—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00278	0.00648	CbGpPWpGaD
Crizotinib—JAK2—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00274	0.00639	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0027	0.0063	CbGpPWpGaD
Crizotinib—PTK2B—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00268	0.00624	CbGpPWpGaD
Crizotinib—NTRK1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00256	0.00598	CbGpPWpGaD
Crizotinib—TYK2—IL23-mediated signaling events—NOS2—sclerosing cholangitis	0.00252	0.00587	CbGpPWpGaD
Crizotinib—ACVR1B—Developmental Biology—TCF4—sclerosing cholangitis	0.0025	0.00583	CbGpPWpGaD
Crizotinib—RPS6KB1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00249	0.00579	CbGpPWpGaD
Crizotinib—PTK2B—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00244	0.00569	CbGpPWpGaD
Crizotinib—RIPK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.0024	0.0056	CbGpPWpGaD
Crizotinib—EPHA2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00236	0.00549	CbGpPWpGaD
Crizotinib—SRC—Angiogenesis—HIF1A—sclerosing cholangitis	0.0023	0.00536	CbGpPWpGaD
Crizotinib—PTK2—Apoptosis—BCL2L11—sclerosing cholangitis	0.00228	0.00531	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00224	0.00522	CbGpPWpGaD
Crizotinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00222	0.00519	CbGpPWpGaD
Crizotinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00221	0.00515	CbGpPWpGaD
Crizotinib—EPHA4—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00217	0.00506	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—TCF4—sclerosing cholangitis	0.00217	0.00505	CbGpPWpGaD
Crizotinib—SRC—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00212	0.00495	CbGpPWpGaD
Crizotinib—SRC—Alpha9 beta1 integrin signaling events—NOS2—sclerosing cholangitis	0.00203	0.00472	CbGpPWpGaD
Crizotinib—JAK2—Type II interferon signaling (IFNG)—NOS2—sclerosing cholangitis	0.00191	0.00445	CbGpPWpGaD
Crizotinib—JAK2—IL23-mediated signaling events—NOS2—sclerosing cholangitis	0.00191	0.00445	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—TCF4—sclerosing cholangitis	0.00189	0.00442	CbGpPWpGaD
Crizotinib—FGR—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00187	0.00435	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—TCF4—sclerosing cholangitis	0.0018	0.00419	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.0018	0.00419	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—TCF4—sclerosing cholangitis	0.0018	0.00419	CbGpPWpGaD
Crizotinib—RIPK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00178	0.00415	CbGpPWpGaD
Crizotinib—CYP3A5—liver—sclerosing cholangitis	0.00177	0.00311	CbGeAlD
Crizotinib—TYK2—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00176	0.00411	CbGpPWpGaD
Crizotinib—JAK2—Notch-mediated HES/HEY network—HIF1A—sclerosing cholangitis	0.00173	0.00404	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—TCF4—sclerosing cholangitis	0.00173	0.00404	CbGpPWpGaD
Crizotinib—PTK2—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00173	0.00402	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—TCF4—sclerosing cholangitis	0.00171	0.00399	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—TCF4—sclerosing cholangitis	0.00171	0.00399	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—TCF4—sclerosing cholangitis	0.00171	0.00399	CbGpPWpGaD
Crizotinib—TYK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00171	0.00399	CbGpPWpGaD
Crizotinib—NTRK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00168	0.00391	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—TCF4—sclerosing cholangitis	0.00168	0.00391	CbGpPWpGaD
Crizotinib—JAK2—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00166	0.00388	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00163	0.0038	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.00161	0.00376	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—ABCB4—sclerosing cholangitis	0.00154	0.0036	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—TCF4—sclerosing cholangitis	0.00151	0.00353	CbGpPWpGaD
Crizotinib—ABCB1—pancreas—sclerosing cholangitis	0.00148	0.00259	CbGeAlD
Crizotinib—JAK2—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00147	0.00342	CbGpPWpGaD
Crizotinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00145	0.00339	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00142	0.00331	CbGpPWpGaD
Crizotinib—JAK2—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00141	0.00328	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TCF4—sclerosing cholangitis	0.0014	0.00326	CbGpPWpGaD
Crizotinib—MERTK—Hemostasis—NOS2—sclerosing cholangitis	0.00139	0.00323	CbGpPWpGaD
Crizotinib—JAK2—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00134	0.00312	CbGpPWpGaD
Crizotinib—CYP3A4—liver—sclerosing cholangitis	0.00133	0.00233	CbGeAlD
Crizotinib—JAK2—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00132	0.00308	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00131	0.00304	CbGpPWpGaD
Crizotinib—JAK2—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.0013	0.00302	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00129	0.00301	CbGpPWpGaD
Crizotinib—TYK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00127	0.00296	CbGpPWpGaD
Crizotinib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00123	0.00287	CbGpPWpGaD
Crizotinib—MAPK7—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00123	0.00286	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00121	0.00283	CbGpPWpGaD
Crizotinib—JAK2—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.0012	0.0028	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00114	0.00265	CbGpPWpGaD
Crizotinib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00114	0.00265	CbGpPWpGaD
Crizotinib—SRC—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00109	0.00254	CbGpPWpGaD
Crizotinib—SRC—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00104	0.00242	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00103	0.00241	CbGpPWpGaD
Crizotinib—SRC—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00102	0.00239	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000966	0.00225	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000961	0.00224	CbGpPWpGaD
Crizotinib—ABCB1—liver—sclerosing cholangitis	0.000942	0.00165	CbGeAlD
Crizotinib—SRC—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.000932	0.00217	CbGpPWpGaD
Crizotinib—SRC—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.000921	0.00215	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TCF4—sclerosing cholangitis	0.000866	0.00202	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000865	0.00202	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000865	0.00202	CbGpPWpGaD
Crizotinib—NTRK1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000861	0.00201	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TCF4—sclerosing cholangitis	0.000855	0.00199	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000842	0.00196	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00082	0.00191	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TCF4—sclerosing cholangitis	0.000787	0.00183	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00075	0.00175	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.000745	0.00174	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—GOT2—sclerosing cholangitis	0.000733	0.00171	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000656	0.00153	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—NOS2—sclerosing cholangitis	0.000649	0.00151	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000637	0.00149	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.000634	0.00148	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—GOT1—sclerosing cholangitis	0.000633	0.00148	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—GGT1—sclerosing cholangitis	0.000633	0.00148	CbGpPWpGaD
Crizotinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000606	0.00141	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TCF4—sclerosing cholangitis	0.000596	0.00139	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000593	0.00138	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00058	0.00135	CbGpPWpGaD
Crizotinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000551	0.00129	CbGpPWpGaD
Crizotinib—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.000537	0.00125	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000517	0.0012	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—NOS2—sclerosing cholangitis	0.000489	0.00114	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TCF4—sclerosing cholangitis	0.000462	0.00108	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000451	0.00105	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000439	0.00102	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000429	0.001	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—NOS2—sclerosing cholangitis	0.000418	0.000975	CbGpPWpGaD
Crizotinib—CDK7—Disease—GOT2—sclerosing cholangitis	0.000405	0.000945	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000382	0.000891	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000377	0.000878	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000368	0.000858	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000368	0.000858	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000361	0.00084	CbGpPWpGaD
Crizotinib—CDK7—Disease—GOT1—sclerosing cholangitis	0.00035	0.000815	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00035	0.000815	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000349	0.000813	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—NOS2—sclerosing cholangitis	0.000342	0.000798	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—NOS2—sclerosing cholangitis	0.000338	0.000787	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000319	0.000744	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.0003	0.000699	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000296	0.000689	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000281	0.000654	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000279	0.00065	CbGpPWpGaD
Crizotinib—TYK2—Disease—GOT2—sclerosing cholangitis	0.000275	0.000642	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000272	0.000635	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000252	0.000588	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000252	0.000587	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000251	0.000584	CbGpPWpGaD
Crizotinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000249	0.000581	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000247	0.000576	CbGpPWpGaD
Crizotinib—CDK7—Disease—HIF1A—sclerosing cholangitis	0.000243	0.000567	CbGpPWpGaD
Crizotinib—TYK2—Disease—GOT1—sclerosing cholangitis	0.000238	0.000554	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—NOS2—sclerosing cholangitis	0.000236	0.000549	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.000224	0.000522	CbGpPWpGaD
Crizotinib—CDK7—Disease—NOS2—sclerosing cholangitis	0.000221	0.000516	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000221	0.000514	CbGpPWpGaD
Crizotinib—JAK2—Disease—GOT2—sclerosing cholangitis	0.000209	0.000487	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000206	0.000481	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.000206	0.000481	CbGpPWpGaD
Crizotinib—LCK—Disease—GOT2—sclerosing cholangitis	0.000183	0.000426	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—NOS2—sclerosing cholangitis	0.000183	0.000426	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000182	0.000425	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000181	0.000421	CbGpPWpGaD
Crizotinib—JAK2—Disease—GOT1—sclerosing cholangitis	0.00018	0.00042	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000169	0.000394	CbGpPWpGaD
Crizotinib—TYK2—Disease—HIF1A—sclerosing cholangitis	0.000165	0.000386	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000163	0.000379	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT2—sclerosing cholangitis	0.000162	0.000377	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.00016	0.000374	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00016	0.000373	CbGpPWpGaD
Crizotinib—LCK—Disease—GOT1—sclerosing cholangitis	0.000158	0.000368	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000153	0.000357	CbGpPWpGaD
Crizotinib—TYK2—Disease—NOS2—sclerosing cholangitis	0.00015	0.000351	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000149	0.000347	CbGpPWpGaD
Crizotinib—SRC—Disease—GOT1—sclerosing cholangitis	0.00014	0.000326	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000128	0.000297	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000126	0.000293	CbGpPWpGaD
Crizotinib—JAK2—Disease—HIF1A—sclerosing cholangitis	0.000125	0.000292	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000119	0.000278	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000116	0.00027	CbGpPWpGaD
Crizotinib—JAK2—Disease—NOS2—sclerosing cholangitis	0.000114	0.000266	CbGpPWpGaD
Crizotinib—LCK—Disease—HIF1A—sclerosing cholangitis	0.00011	0.000256	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000106	0.000248	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000104	0.000242	CbGpPWpGaD
Crizotinib—LCK—Disease—NOS2—sclerosing cholangitis	9.99e-05	0.000233	CbGpPWpGaD
Crizotinib—SRC—Disease—HIF1A—sclerosing cholangitis	9.72e-05	0.000227	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	9.38e-05	0.000219	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	9.18e-05	0.000214	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	9.18e-05	0.000214	CbGpPWpGaD
Crizotinib—SRC—Disease—NOS2—sclerosing cholangitis	8.84e-05	0.000206	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—HIF1A—sclerosing cholangitis	8.78e-05	0.000205	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	8.02e-05	0.000187	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	7.69e-05	0.000179	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	6.92e-05	0.000161	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	6.92e-05	0.000161	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—HIF1A—sclerosing cholangitis	6.81e-05	0.000159	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	4.94e-05	0.000115	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.27e-05	9.94e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.27e-05	9.94e-05	CbGpPWpGaD
